Recently disclosed documents show Anthony Fauci’s institute worked in direct partnership with the CIA on forensic microbiology projects, raising sharp questions about oversight and blurred lines between national security and public health.
Records obtained by the Daily Caller News Foundation detail a collaboration between the CIA’s Biological Technology Center and the National Institute of Allergy and Infectious Diseases (NIAID), then under the direction of Anthony Fauci, focused on “forensic microbiology” research into pathogens relevant to bioterrorism. The agreement, described in the documents but undated, involved several federal agencies and private partners and set out terms for sharing sensitive biological data, funding, and research efforts.
According to the Daily Caller News Foundation’s reporting, the CIA planned to use its funds to leverage existing civilian research at NIAID and the Institute for Genomic Research (TIGR), a private nonprofit located near the National Institutes of Health headquarters in Rockville, Maryland. The CIA would help NIAID obtain biological agents for study and required that data produced under the agreement could not be shared without CIA permission. The collaboration was intended to “augment and complement” the CIA’s research and development in detecting and analyzing biological threats.
The documents reveal that these efforts were part of a broader federal push in the early 2000s to ramp up U.S. biodefense capabilities. Rutgers chemistry professor Richard Ebright, who reviewed the documents, stated, “Vice President Cheney assigned Fauci to head US biodefense research programs in 2002, including bioweapons-agents-development and bioweapons-agents-characterization research programs that approached, and arguably crossed, red lines set by the Biological Weapons Convention.” Ebright added, “The documents show early steps in the process of transferring funding for, and direction of, CIA and DoD biodefense projects to Fauci’s agency, NIAID.”
The CIA’s interest in this partnership is further described in a November 2003 memo titled “The Darker Bioweapons Future,” which called for “a much closer, and perhaps qualitatively different, working relationship between the intelligence and biological sciences communities.” The memo argued that biological weapons were harder to detect than nuclear threats and that the intelligence community needed to expand its presence in biology labs worldwide, echoing recommendations from a National Academy of Sciences expert group.
These new disclosures add to a growing record of concern about the lack of oversight when national security agencies and public health bodies operate in tandem. Jim Erdman, a former senior operations officer at the CIA and a declassification task force member under former Director of National Intelligence Tulsi Gabbard, submitted testimony to Sen. Rand Paul’s committee describing the risks of such collaboration. “The lines between public health and biodefense have been blurred beyond recognition ever since,” Erdman wrote. He noted that for more than 20 years, “There was no oversight monitoring how this web of relationships influenced research, policy, and public health in any holistic way.”
Erdman’s testimony described a world in which scientists worked on “sensitive WMD topics” under contracts for intelligence agencies, while some of their research also contributed to open-source academic papers funded by civilian health agencies. Vaccine research, according to Erdman, drew funding not just from public health sources but also from the CIA, USAID, Pentagon, and international partners, including collaborations with Chinese scientists on coronavirus studies. These revelations echo the ongoing scrutiny of Fauci’s operations and the tangled web of government, academic, and foreign partnerships, as seen in cases like the guilty plea of Fauci’s former adviser David Morens for conspiracy to hide COVID-19 records.
The details also underscore why Fauci’s record has come under intense congressional and legal scrutiny in recent years. Senator Rand Paul, who has led efforts to probe Fauci’s activities, questioned him at a July 29 hearing about whether the CIA provided funds to the NIH or conducted research in partnership with intelligence agencies. That hearing and related findings have fueled broader investigations, including a Senate committee vote to hold Fauci in contempt and ongoing debates about the limits of executive power and accountability for senior officials.
Despite these revelations, much about the CIA, NIAID partnership remains hidden from public view. The interagency agreement itself is undated, and key details, including the specific “forensic comparative analyses” referenced, the identities of all collaborating partners, and the list of pathogens studied, remain redacted or undisclosed. The nature of the collaboration, including which projects were conducted and how much funding was transferred, is left unclear by the available documents.
Senator Paul’s investigation reflects the broader skepticism among lawmakers and the public about the wisdom of allowing intelligence agencies to operate with minimal oversight in areas that affect civilian health and scientific research. As past reporting has shown, Fauci’s legal team has scrambled to respond as state and federal probes pile up, and questions about his relationship with the intelligence community have only grown louder.
In addition to the CIA and NIAID, the Institute for Genomic Research, now known as the J. Craig Venter Institute, played a key role as a private partner, operating just outside NIH headquarters in Maryland. The documents describe efforts to build a “specific capability in forensic microbiology” through partnerships, though the identity of at least one major partner is redacted. The collaboration produced a research program in “Integrated Bio-threat Forensics-Systems Biology” that, according to the agreement, was unique at the time.
This new evidence adds to the mounting body of documentation tying Fauci and NIAID to intelligence-driven biodefense projects, a subject that has sparked controversy and further investigation. Readers can find more on the origins and scope of this partnership in our report on newly obtained documents revealing the CIA-NIAID partnership under Fauci.
The steady post-9/11 expansion of U.S. biodefense research was driven in part by President George W. Bush’s call for increased funding for biological weapons defense in his January 2003 State of the Union address. As federal resources flowed into NIH and NIAID, Fauci’s institute became a central hub for both civilian and intelligence community interests in biosecurity. Richard Ebright’s warning that U.S. research “approached, and arguably crossed, red lines” set by the Biological Weapons Convention highlights the risks when scientific boundaries become flexible in the name of security.
Rising public concern about these blurred lines has been fueled by investigations into Fauci’s role and his frequent invocation of the Fifth Amendment in congressional proceedings, as detailed in the debate over whether a presidential pardon could protect him from legal consequences. These legal maneuvers and the secrecy surrounding the CIA-NIAID collaboration have only deepened doubts about whether proper oversight ever existed.
Even as more documents come to light, accountability remains elusive. The decades-long lack of transparency and external review described by Jim Erdman stands as a stark warning: “There was no oversight monitoring how this web of relationships influenced research, policy, and public health in any holistic way for over 20 years.”
For Americans who expect clear lines between intelligence operations and public health, the partnership between Fauci’s NIAID and the CIA raises tough questions, not just about the past, but about the future of government transparency and constitutional order.
